PL381614A1 - Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia - Google Patents

Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia

Info

Publication number
PL381614A1
PL381614A1 PL381614A PL38161405A PL381614A1 PL 381614 A1 PL381614 A1 PL 381614A1 PL 381614 A PL381614 A PL 381614A PL 38161405 A PL38161405 A PL 38161405A PL 381614 A1 PL381614 A1 PL 381614A1
Authority
PL
Poland
Prior art keywords
system diseases
derivatives
central nervous
indoline
treating central
Prior art date
Application number
PL381614A
Other languages
English (en)
Inventor
Balazs Volk
Jozsef Barkoczy
Gyula Simig
Tibor Mezei
Dezsofi Rita Kapillerne
Istvan Gacsalyi
Katalin Pallagi
Gabor Gigler
Gyorgy Levay
Krisztina Moricz
Csilla Leveleki
Nora Sziray
Gabor Szenasi
Andras Egyed
Laszlo Gabor Harsing
Original Assignee
Egis Gyogyszergyar Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0400955A external-priority patent/HU0400955D0/hu
Priority claimed from HU0500463A external-priority patent/HUP0500463A3/hu
Application filed by Egis Gyogyszergyar Nyrt. filed Critical Egis Gyogyszergyar Nyrt.
Publication of PL381614A1 publication Critical patent/PL381614A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL381614A 2004-05-11 2005-05-11 Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia PL381614A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400955A HU0400955D0 (en) 2004-05-11 2004-05-11 Pyridine derivatives of dialkyl oxindoles
HU0500463A HUP0500463A3 (en) 2005-05-05 2005-05-05 Pyridine derivatives of dialkyl-oxindoles

Publications (1)

Publication Number Publication Date
PL381614A1 true PL381614A1 (pl) 2007-06-11

Family

ID=89985998

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05745439T PL1751138T3 (pl) 2004-05-11 2005-05-11 Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia
PL381614A PL381614A1 (pl) 2004-05-11 2005-05-11 Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL05745439T PL1751138T3 (pl) 2004-05-11 2005-05-11 Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia

Country Status (21)

Country Link
US (2) US20070232662A1 (pl)
EP (1) EP1751138B9 (pl)
JP (1) JP2007537228A (pl)
KR (1) KR20070014189A (pl)
AT (1) ATE382045T1 (pl)
AU (1) AU2005240844A1 (pl)
BG (1) BG109770A (pl)
CA (1) CA2566426A1 (pl)
CZ (1) CZ2006772A3 (pl)
DE (1) DE602005004024T2 (pl)
EA (1) EA010865B1 (pl)
ES (1) ES2299033T3 (pl)
HR (2) HRP20080129T3 (pl)
IL (1) IL179030A0 (pl)
MX (1) MXPA06013065A (pl)
NO (1) NO20065661L (pl)
PL (2) PL1751138T3 (pl)
PT (1) PT1751138E (pl)
RS (1) RS20060622A (pl)
SK (1) SK51062006A3 (pl)
WO (1) WO2005108390A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK51052006A3 (sk) * 2004-05-11 2007-05-03 Egis Gy�gyszergy�r Nyrt. Pyridínové deriváty alkyloxindolov ako aktívne látky voči 5-HT7 receptoru
PL1776339T3 (pl) * 2004-05-11 2009-12-31 Egis Gyogyszergyar Nyrt Pochodne 3-(((-4-fenylo)-piperazyn-1-ylo)-alkilo)-3-alkilo-1,3-dihydro-2H-indol-2-onu i związki pokrewne do leczenia chorób centralnego układu nerwowego

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
US6407112B1 (en) * 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative
FR2779429B1 (fr) * 1998-06-03 2000-07-13 Synthelabo Derives d'oxindole, leurs preparations et leurs applications en therapeutique
AR035521A1 (es) * 2000-12-22 2004-06-02 Lundbeck & Co As H Derivados de 3-indolina y composicion farmaceutica que los comprende

Also Published As

Publication number Publication date
SK51062006A3 (sk) 2007-04-05
JP2007537228A (ja) 2007-12-20
AU2005240844A1 (en) 2005-11-17
EP1751138B1 (en) 2007-12-26
EA200602082A1 (ru) 2007-04-27
MXPA06013065A (es) 2007-05-04
WO2005108390A1 (en) 2005-11-17
HRP20060403A2 (en) 2007-04-30
ATE382045T1 (de) 2008-01-15
EP1751138A1 (en) 2007-02-14
PL1751138T3 (pl) 2008-05-30
CA2566426A1 (en) 2005-11-17
US20070232662A1 (en) 2007-10-04
EP1751138B9 (en) 2008-11-12
RS20060622A (sr) 2008-06-05
HRP20080129T3 (en) 2008-04-30
IL179030A0 (en) 2007-03-08
KR20070014189A (ko) 2007-01-31
PT1751138E (pt) 2008-02-25
ES2299033T3 (es) 2008-05-16
US20090281137A1 (en) 2009-11-12
DE602005004024D1 (de) 2008-02-07
EA010865B1 (ru) 2008-12-30
BG109770A (bg) 2008-05-30
NO20065661L (no) 2007-02-08
DE602005004024T2 (de) 2008-12-24
CZ2006772A3 (cs) 2007-03-14

Similar Documents

Publication Publication Date Title
MY144483A (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
EA200600048A1 (ru) Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
NO20045589L (no) Nye forbindelser
YU21702A (sh) Supstituisani indoli za moduliranje nfkb aktivnosti
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
MX2009007104A (es) Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina.
TW200616953A (en) Indole, indazole or indoline derivatives
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
MY153719A (en) Prokineticin 1 receptor antagonists
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
EA200602083A1 (ru) Новые пиперазиновые производные диалкилоксиндолов
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
IL179030A0 (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
MXPA04001977A (es) Antagonistas v de receptor ccr-3.
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
MX2008001033A (es) Derivados de 4-ariloxi quinolina como moduladores de 5-ht6.
UA86978C2 (en) Piperazine derivatives of dialkyl oxindoles
EA200602084A1 (ru) Пиперазиновые производные алкилоксиндолов

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)